TY - JOUR
T1 - The allergic effector unit
T2 - From basic science to drug-targetable mast cell–eosinophil interactions in patients
AU - Puzzovio, Pier Giorgio
AU - Levi-Schaffer, Francesca
N1 - Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem. Funding Information: This study was funded by Rosetrees Trust (UK), Aimwell Charitable Trust (UK), Israel Science Foundation (Grant no. 442/18), Israel Ministry of Science & Technology, and Emalie Gutterman Memorial Endowed Fund for COPD Related Research (USA). F. Levi-Schaffer is affiliated with the Adolph and Klara Brettler Center for Molecular Pharmacology and Therapeutics at the School of Pharmacy of the Hebrew University of Jerusalem.
PY - 2021/10
Y1 - 2021/10
UR - http://www.scopus.com/inward/record.url?scp=85115930745&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.jaip.2021.07.008
DO - https://doi.org/10.1016/j.jaip.2021.07.008
M3 - رسالة
C2 - 34627540
SN - 2213-2198
VL - 9
SP - 3845
EP - 3846
JO - Journal of Allergy and Clinical Immunology: In Practice
JF - Journal of Allergy and Clinical Immunology: In Practice
IS - 10
ER -